Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30272171.
- Also identified by DOI 10.1210/jc.2018-01865 and PMC identifier 6456929.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010. The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.
Medical subject headings
- Adrenal Hyperplasia, Congenital
- Endocrinology
- Societies, Medical